Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CRISPR Therapeutics AG (CRSP)

48.5   -0.78 (-1.58%) 07-16 16:00
Open: 49.38 Pre. Close: 49.28
High: 49.58 Low: 47.935
Volume: 425,764 Market Cap: 2659M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.115 - 50.362 50.362 - 50.612
Low: 47.974 - 48.228 48.228 - 48.485
Close: 48.871 - 49.274 49.274 - 49.683

Technical analysis

as of: 2019-07-16 3:19:53 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 58.69     One year: 68.55
Support: Support1: 44.84    Support2: 41.49
Resistance: Resistance1: 50.25    Resistance2: 58.69
Pivot: 47.43
Moving Average: MA(5): 49.13     MA(20): 46.99
MA(100): 40.19     MA(250): 39.84
MACD: MACD(12,26): 1.89     Signal(9): 1.93
Stochastic oscillator: %K(14,3): 81.20     %D(3): 85.08
RSI: RSI(14): 59.61
52-week: High: 61.97  Low: 22.22  Change(%): -22.2
Average Vol(K): 3-Month: 51722  10-Days: 37163

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CRSP has closed below upper band by 37.9%. Bollinger Bands are 8.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 10 Jul 2019 14:08:59 Z
Here's Why CRISPR Gene Editing Stocks Rose as Much as 32.4% in June

Sat, 29 Jun 2019 22:06:46 Z
3 Growth Stocks to Buy and Hold for the Next 50 Years

Tue, 11 Jun 2019 11:08:16 Z
Is the Newest Gene Editing Stock a Buy?

Mon, 10 Jun 2019 15:15:25 Z
CRISPR Therapeutics Up on Collaboration Expansion by Vertex

Sun, 09 Jun 2019 18:15:42 Z
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 30.36
% Held by Insiders 41.38
% Held by Institutions 44.50
Shares Short (K) 5450
Shares Short P. Month (K)

Stock Financials

EPS -3.740
EPS Est. Current Year -2.430
EPS Est. Next Year -3.020
EPS Est. Next Quarter -0.740
Forward EPS -3.299
Book Value (p.s.) 7.220
PEG Ratio
Profit Margin
Operating Margin -8613.61
Return on Assets (ttm) -25.9
Return on Equity (ttm) -55.2
Qtrly Rev. Growth -75.8
Gross Profit (p.s.) -2.092
Sales Per Share
EBITDA (p.s.) -3.345
Qtrly Earnings Growth
Operating Cash Flow (M) -117.29
Levered Free Cash Flow (M) -66.90

Stock Valuations

P/E -12.91
P/E Growth Ratio -0.02
P/BV 6.69
P/S 63812939776.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.